Welcome to another episode of Category Visionaries, the show that explores the future of tech with innovative B2B founders. In today's episode, we're speaking with Joe Gagnon, CEO of 1upHealth, a healthcare data platform that has raised over $75 million in funding.

• Joe's passion for endurance sports and pushing the boundaries of human potential, epitomized by his experience running a marathon on six continents in six days, covering 157 miles and 37,000 miles of travel.
• The importance of embracing challenges and discomfort to develop problem-solving skills and resilience, both in endurance sports and in business leadership.
• 1upHealth's mission to build a cloud-based, modern data platform for healthcare, enabling interoperability and computation across payers, providers, patients, and pharma companies.
• The historical and structural reasons behind healthcare's lag in adopting technology and data standards, leading to inefficiencies, high costs, and poor care quality.
• 1upHealth's focus on selling to payers (insurance companies) as their primary customer, leveraging the need for compliance with federal data standards and communication requirements.
• The company's impressive growth trajectory, ranking 35th on Deloitte's Fast 500 list with 5,100% growth from 2019 to 2022, along with 10x employee growth and significant funding rounds.
• The challenges and learnings from transitioning from a founder-led company to a professional CEO, and the importance of aligning skill sets with the stage and needs of the business.
• The competitive landscape in healthcare data, spanning cloud providers, health application companies, and data warehouse players, and the value of having competitors validate the market opportunity.
• The shift in market category from a regulatory compliance solution to a data lakehouse as 1upHealth scales and accumulates billions of records and trillions of resources.
• The impact of the macroeconomic slowdown on enterprise selling and the need for tighter operational control and market responsiveness.